{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:11:40Z","timestamp":1793319100002,"version":"4.5.0"},"reference-count":54,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["Projet ANR-18-CE14-0005"],"award-info":[{"award-number":["Projet ANR-18-CE14-0005"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["PGA1 RF20180206809"],"award-info":[{"award-number":["PGA1 RF20180206809"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondation Princesse Grace"},{"name":"Association Francaise Des Intol\u00e9rants au Gluten"},{"name":"Investissement d'Avenir","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,1,27]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Enteropathy-associated T-cell lymphoma (EATL) is a rare but severe complication of coeliac disease (CeD), often preceded by low-grade clonal intraepithelial lymphoproliferation, referred to as type II refractory CeD (RCDII). Knowledge on underlying oncogenic mechanisms remains scarce. Here, we analysed and compared the mutational landscape of RCDII and EATL in order to identify genetic drivers of CeD-associated lymphomagenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Pure populations of RCDII-cells derived from intestinal biopsies (n=9) or sorted from blood (n=2) were analysed by whole exome sequencing, comparative genomic hybridisation and RNA sequencing. Biopsies from RCDII (n=50), EATL (n=19), type I refractory CeD (n=7) and uncomplicated CeD (n=18) were analysed by targeted next-generation sequencing. Moreover, functional in vitro studies and drug testing were performed in RCDII-derived cell lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>80% of RCDII and 90% of EATL displayed somatic gain-of-functions mutations in the JAK1-STAT3 pathway, including a remarkable p.G1097 hotspot mutation in the JAK1 kinase domain in approximately 50% of cases. Other recurrent somatic events were deleterious mutations in nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-\u03baB) regulators TNFAIP3 and TNIP3 and potentially oncogenic mutations in TET2, KMT2D and DDX3X. JAK1 inhibitors, and the proteasome inhibitor bortezomib could block survival and proliferation of malignant RCDII-cell lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mutations activating the JAK1-STAT3 pathway appear to be the main drivers of CeD-associated lymphomagenesis. In concert with mutations in negative regulators of NF-\u03baB, they may favour the clonal emergence of malignant lymphocytes in the cytokine-rich coeliac intestine. The identified mutations are attractive therapeutic targets to treat RCDII and block progression towards EATL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2020-322935","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T03:55:01Z","timestamp":1613188501000},"page":"497-508","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":102,"title":["Oncogenetic landscape of lymphomagenesis in coeliac disease"],"prefix":"10.1136","volume":"71","author":[{"given":"Sascha","family":"Cording","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM UMR 1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lhermitte","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Necker-Enfants Malades, INSERM UMR 1151, Paris, France"},{"name":"Laboratory of Onco-Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-3025","authenticated-orcid":false,"given":"Georgia","family":"Malamut","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM UMR 1163, Paris, France"},{"name":"Department of Gastroenterology, AP-HP, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Berrabah","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM UMR 1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Trinquand","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM UMR 1163, Paris, France"},{"name":"Haematology Department, National Children\u2019s Research Centre, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Guegan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM UMR 1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Villarese","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Necker-Enfants Malades, INSERM UMR 1151, Paris, France"},{"name":"Laboratory of Onco-Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kaltenbach","sequence":"additional","affiliation":[{"name":"Department of Cytogenetics, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Meresse","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lille, CHU Lille, INSERM UMR 1286 \u2013 INFINITE \u2013 Institute for Translational Research in Inflammation, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Khater","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dussiot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR 1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bras","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Bioinformatics Platform, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Cheminant","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR 1163, Paris, France"},{"name":"Clinical Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Tesson","sequence":"additional","affiliation":[{"name":"Institut Carnot CALYM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bole-Feysot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Genomics Platform, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[{"name":"Department of Pathology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry Jo","family":"Molina","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR 1163, Paris, France"},{"name":"Department of Pathology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sibon","sequence":"additional","affiliation":[{"name":"Clinical Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Macintyre","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Necker-Enfants Malades, INSERM UMR 1151, Paris, France"},{"name":"Laboratory of Onco-Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR 1163, Paris, France"},{"name":"Clinical Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cellier","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Necker-Enfants Malades, INSERM UMR 1151, Paris, France"},{"name":"Laboratory of Onco-Haematology, AP-HP, H\u00f4pital Necker Enfants-Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-1245","authenticated-orcid":false,"given":"Nadine","family":"Cerf-Bensussan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM UMR 1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"2025090723022998000_71.3.497.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2018.09.004"},{"key":"2025090723022998000_71.3.497.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70530-X"},{"key":"2025090723022998000_71.3.497.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02481-8"},{"key":"2025090723022998000_71.3.497.4","first-page":"1","article-title":"Enteropathy-Associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes","volume":"132","author":"Spencer","year":"1988","journal-title":"Am J Pathol"},{"key":"2025090723022998000_71.3.497.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.069"},{"key":"2025090723022998000_71.3.497.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.013"},{"key":"2025090723022998000_71.3.497.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.12.001"},{"key":"2025090723022998000_71.3.497.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)01047-3"},{"key":"2025090723022998000_71.3.497.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.06.018"},{"key":"2025090723022998000_71.3.497.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.018"},{"key":"2025090723022998000_71.3.497.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317371"},{"key":"2025090723022998000_71.3.497.12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.205"},{"key":"2025090723022998000_71.3.497.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0322-z"},{"key":"2025090723022998000_71.3.497.14","unstructured":"Swerdlow SH , Campo E , Harris NL . WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France. World Heal Organ Calssification Tumours Haematop Lymphoid Tissue, 2017."},{"key":"2025090723022998000_71.3.497.15","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830170910"},{"key":"2025090723022998000_71.3.497.16","first-page":"509","article-title":"Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma","volume":"146","author":"Murray","year":"1995","journal-title":"Am J Pathol"},{"key":"2025090723022998000_71.3.497.17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12602"},{"key":"2025090723022998000_71.3.497.18","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0177-y"},{"key":"2025090723022998000_71.3.497.19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3358"},{"key":"2025090723022998000_71.3.497.20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.2019791475","article-title":"Dysregulation of the Tet family of epigenetic regulators in lymphoid and myeloid malignancies","volume":"134","author":"Lio","year":"2019","journal-title":"Blood"},{"key":"2025090723022998000_71.3.497.21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052204"},{"key":"2025090723022998000_71.3.497.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.02.009"},{"key":"2025090723022998000_71.3.497.23","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2775"},{"key":"2025090723022998000_71.3.497.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2016.09.003"},{"key":"2025090723022998000_71.3.497.25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081143"},{"key":"2025090723022998000_71.3.497.26","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2018-0195"},{"key":"2025090723022998000_71.3.497.27","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3415"},{"key":"2025090723022998000_71.3.497.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04013-1"},{"key":"2025090723022998000_71.3.497.29","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2017.134"},{"key":"2025090723022998000_71.3.497.30","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.2855"},{"key":"2025090723022998000_71.3.497.31","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.71"},{"key":"2025090723022998000_71.3.497.32","first-page":"471","article-title":"Advances in the understanding of mechanisms and therapeutic use of bortezomib","volume":"12","author":"Mujtaba","year":"2011","journal-title":"Discov Med"},{"key":"2025090723022998000_71.3.497.33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.019745"},{"key":"2025090723022998000_71.3.497.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-111948"},{"key":"2025090723022998000_71.3.497.35","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3806"},{"key":"2025090723022998000_71.3.497.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.006"},{"key":"2025090723022998000_71.3.497.37","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0187-8"},{"key":"2025090723022998000_71.3.497.38","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.13"},{"key":"2025090723022998000_71.3.497.39","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.178"},{"key":"2025090723022998000_71.3.497.40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-830968"},{"key":"2025090723022998000_71.3.497.41","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001904"},{"key":"2025090723022998000_71.3.497.42","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230961"},{"key":"2025090723022998000_71.3.497.43","doi-asserted-by":"publisher","DOI":"10.1038\/nri2670"},{"key":"2025090723022998000_71.3.497.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.06.006"},{"key":"2025090723022998000_71.3.497.45","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.169052"},{"key":"2025090723022998000_71.3.497.46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01594.x"},{"key":"2025090723022998000_71.3.497.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620036114"},{"key":"2025090723022998000_71.3.497.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.11.005"},{"key":"2025090723022998000_71.3.497.49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-170597"},{"key":"2025090723022998000_71.3.497.50","doi-asserted-by":"crossref","first-page":"1485-1495","DOI":"10.1177\/2050640618800540","article-title":"Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: consequences for follow-up: celiac disease, lymphoma and Gi carcinoma","volume":"6","author":"van Gils","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"2025090723022998000_71.3.497.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.05.033"},{"key":"2025090723022998000_71.3.497.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0273-0"},{"key":"2025090723022998000_71.3.497.53","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.01.004"},{"key":"2025090723022998000_71.3.497.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.009"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2020-322935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:02:37Z","timestamp":1757311357000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2020-322935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2,8]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/gutjnl-2020-322935"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2020-322935","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.07.275032","asserted-by":"object"}]},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}